Related Experiment Video
Updated: Oct 6, 2025

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
Deep learning identified glioblastoma subtypes based on internal genomic expression ranks
Xing-Gang Mao1, Xiao-Yan Xue2, Ling Wang3
1Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi Province, People's Republic of China.
A new algorithm unifies glioblastoma (GBM) genomic data into standardized normal distribution (SND) for improved classification. Convolutional deep neural networks (CDNN) trained on SND data achieve higher accuracy, suggesting the Neural (NE) subtype may not fit the current classification system.
Area of Science:
- Computational biology
- Genomics
- Machine learning in oncology
Background:
- Glioblastoma (GBM) exhibits distinct genomic subtypes (Proneural, Neural, Classical, Mesenchymal).
- Standardizing diverse genomic expression profiles for GBM subtype classification is challenging.
- Manual classification of GBM samples into subtypes is difficult.
Purpose of the Study:
- To develop an algorithm for unifying heterogeneous GBM genomic profiles.
- To train and evaluate deep neural network (DNN) and convolutional DNN (CDNN) models using standardized data.
- To assess the accuracy and generalization capacity of CDNN models for GBM subtyping.
Main Methods:
- Developed a novel algorithm to transform GBM genomic profiles into a standardized normal distribution (SND) based on gene expression ranks.
- Trained DNN and CDNN models on both original and SND GBM datasets.
- Utilized expanded TCGA datasets to enhance CDNN model robustness and generalization.
Main Results:
- SND transformation preserved data distribution and internal gene expression ranks.
- CDNN models trained on SND data significantly outperformed models trained on primary data.
- CDNN models demonstrated high accuracy across various GBM datasets, including independent ones.
- The Neural (NE) subtype was consistently classified with lower accuracy, supporting its potential exclusion.
Conclusions:
- Unified SND data enables the training of highly accurate and generalizable CDNN models for GBM classification.
- The developed CDNN models offer a robust tool for GBM subtyping.
- Findings suggest the Neural (NE) subtype may be incompatible with the established 4-subtype classification system for glioblastoma.
More Related Videos
09:09Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
Published on: April 12, 2020
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019